Top Markets
#1 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +22.72%
#2 Ocean Protocol Ocean Protocol +16.45%
#3 Cysic Cysic +16.43%
#4 KUB Coin KUB Coin +15.39%
#5 Audiera Audiera +10.87%
#6 Geodnet Geodnet +10.71%
#7 Quack AI Quack AI +10.35%
#8 Perle Perle +10.31%
#9 Tutorial Tutorial +10.22%
#10 Arowana Arowana +10.11%
Coin of the day
FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock)
Einstellungen
Sprache
DEUTSCH
Währung
USD
Thema
Hoth Therapeutics, Inc. Hoth Therapeutics, Inc.

Hoth Therapeutics, Inc.

HOTH
Rang in Aktien #32247
Hoth Therapeutics, Inc. engages in the development of new generation therapies... Hoth Therapeutics, Inc. engages in the development of new generation therapies for dermatological disorders. Its product pipeline focuses on potential treatments for indications including atopic dermatitis (also known as eczema), chronic wounds, psoriasis, asthma, and acne. It offers the BioLexa Platform, a drug compound platform for the treatment of eczema. The company was founded by Robbie Knie, Matthew D. Eitner, and James Ahern on May 16, 2017 and is headquartered in New York, NY.
Aktienkurs
$0.8013
Zuletzt synchronisiert: 2026-08-05
Marktkapitalisierung
$10.62M
Veränderung (1 Tag)
0.97%
Veränderung (1 Jahr)
-37.88%
Land
US
Handel Hoth Therapeutics, Inc. (HOTH)

Kategorie

Healthcare
Kursverlauf für Hoth Therapeutics, Inc. (HOTH)
Höchster Schlusskurs: $0.80 am 2026-08-01

Niedrigster Schlusskurs: $173.97 am 2019-02-01
Kursverlauf der Aktie von Hoth Therapeutics, Inc. von 2019 bis 2026
Jährliche Kursentwicklung
Jahr Leistung
2026 (TTM) -0.95%
2025 36.59%
2024 -36.83%
2023 -67.73%
2022 -78.42%
2021 -57.08%
2020 -64.80%
2019 0.00%
Aktienkurs vergleichbarer Unternehmen oder Wettbewerber
Unternehmen Aktienkurs Veränderung 1J% Land
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $515.58 32.24%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $992.01 50.00%
NL
CSL Limited CSL Limited
CSL Limited
CSL.AX
 $111.29 -36.83%
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 $736.64 6.99%
CH
Samsung Biologics Co.,Ltd. Samsung Biologics Co.,Ltd.
Samsung Biologics Co.,Ltd.
207940.KS
 $1.06K -6.67%
KR